Rejected Applicant's Petition Says Agency Kept 'Secret' Filing System

For over 14 years, the National Science Foundation has systematically deprived its grant applicants of certain basic legal rights that Congress intended them to have and which other granting agencies, such as the National Institutes of Health have made more of an effort to protect. Because of NSF’s circumvention of these rights, many scientists may have been denied grants for improper reasons—due to conflicts of interest, or because of blatantly erroneous information—without

Written byJon Kalb
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

For over 14 years, the National Science Foundation has systematically deprived its grant applicants of certain basic legal rights that Congress intended them to have and which other granting agencies, such as the National Institutes of Health have made more of an effort to protect. Because of NSF’s circumvention of these rights, many scientists may have been denied grants for improper reasons—due to conflicts of interest, or because of blatantly erroneous information—without even realizing it.

To rectify this situation, we recently submitted an extensive petition to NSF, asking it to make some modest but essential changes in its peer review system—changes that would undermine none of the fundamental principles on which a peer review system is based, but which would make it much fairer and more accountable to grant applicants. It is in the interest of every person who has ever submitted a grant application to NSF. or who may ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies